News Daily News PCI and CABG Are Complementary Options for Left Main CAD, Say Experts Michael O'Riordan April 27, 2022
News Conference News ACC 2022 Managing AF Patients Undergoing PCI—Some Lingering Questions Michael O'Riordan April 12, 2022
News Conference News ACC 2022 Tricuspid Repair With Pascal Safe, Effective at 1 Year: CLASP TR Yael L. Maxwell April 05, 2022
News Conference News ACC 2022 Mavacamten Slashes Need for Septal Reduction in Obstructive HCM: VALOR-HCM Yael L. Maxwell April 02, 2022
News Conference News ACC 2022 SODIUM-HF: No Impact of Tighter Dietary Salt Restriction on Death or Hospitalization L.A. McKeown April 02, 2022
News Daily News Surgical Societies Question VARC-3 Endpoints for Valve Disease Trials Michael O'Riordan March 23, 2022
News Features Aortic Valve Replacement: What’s on the Wish List for Future Devices? Shelley Wood March 14, 2022
News Conference News ISC 2022 Stroke Thrombectomy Also Benefits Kids, Observational Study Shows Todd Neale February 16, 2022
News Conference News ISC 2022 CHOICE: Intra-arterial tPA Enhances Benefit of Stroke Thrombectomy Todd Neale February 11, 2022
News Conference News ISC 2022 ACTION-CVT: DOACs Look Like a Good Option for Cerebral Venous Thrombosis Todd Neale February 10, 2022
News Daily News Female-Specific Data Lacking for Myocardial Revascularization: SCAI Todd Neale February 08, 2022
News Conference News STS 2022 CHOICE-MI: TMVR Mortality Much Lower With Newer Transseptal Devices Todd Neale February 03, 2022
News Opinion Fellow Talk A Trainee’s Perspective on the First Genetically Engineered Pig-to-Human Cardiac Xenotransplantation Corbin E. Goerlich, MD January 13, 2022
News Daily News With First-in-Human Porcine Heart Transplant, a New Chapter Begins Yael L. Maxwell January 11, 2022
News Daily News Statins No Benefit to ICU-Admitted COVID-19 Patients: INSPIRATION-S Caitlin E. Cox January 07, 2022
News Daily News Surgeon Groups Explain Why They Didn’t Endorse New CAD Revascularization Guidelines L.A. McKeown December 28, 2021
News Daily News Apixaban Appears Safer, More Effective Than Rivaroxaban in Medicare Study Todd Neale December 27, 2021